News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Daily News A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex L.A. McKeown March 01, 2019
News Daily News No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds L.A. McKeown March 01, 2019
News Daily News Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices L.A. McKeown February 13, 2019
News Daily News IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease L.A. McKeown January 25, 2019
News Daily News Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies L.A. McKeown January 23, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2018 Caitlin E. Cox January 01, 2019
News Daily News Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD L.A. McKeown December 17, 2018
News Conference News VIVA 2018 VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease L.A. McKeown November 08, 2018
News Conference News VIVA 2018 IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions L.A. McKeown November 06, 2018
News Opinion Off Script TCT 2018 Off Script: Phantom Hearts and the Elusive Nature of Angina Kwan S. Lee October 11, 2018
News Conference News TCT 2018 ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year Lucy Hicks September 24, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Daily News ‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients Michael O'Riordan August 23, 2018
News Daily News REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months L.A. McKeown February 11, 2018